Naloxone

This classification denotes an opiate antagonist with the molecular formula C19H21NO4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 36B82AMQ7N, chemically known as 17-allyl-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one but generally known as naloxone, which bears US NIH Compound Identifier 5284596. European Medicines Agency schedules Naloxone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09142MIG. The term NALOXONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules naloxone in its Anatomical Therapeutic Chemical (ATC) Classification. NALOXONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule naloxone under HS 29391900 and SITC 54141. As of Q4 2014, NALOXONE remains the US FDA Preferred Term for this commodity. Naloxone bears US NLM identifiers UMLS ID C0027358 and NCI Concept Code C62054. SMILES: O1C2C34C(O)(C(N(CC3)CC=C)CC3C4C1C(O)CC3)CCC2=O.